Analysis of 11 candidate genes in 849 adult patients with suspected hereditary cancer predisposition
Open Access
- 25 October 2020
- journal article
- research article
- Published by Wiley in Genes, Chromosomes and Cancer
- Vol. 60 (2) , 73-78
Abstract
Hereditary predisposition to cancer concerns between 5% and 10% of cancers. The main genes involved in the most frequent syndromes (hereditary breast and ovarian cancer syndrome, hereditary nonpolyposis colorectal cancer syndrome) were identified in the 1990s. Exploration of their functional pathways then identified novel genes for hereditary predisposition to cancer, and candidate genes whose involvement remains unclear. To determine the contribution of truncating variants in 11 candidate genes (BARD1, FAM175A, FANCM, MLH3, MRE11A, PMS1, RAD50, RAD51, RAD51B, RINT1, and XRCC2) to cancer predisposition in a population of interest, panel sequencing was performed in 849 patients with a suspected hereditary predisposition to cancer for whom a diagnostic panel of 38 genes identified no causal mutation. Sixteen truncating variants were found in FANCM (n = 7), RINT1 (n = 4), RAD50 (n = 2), BARD1, PMS1, and RAD51B. FANCM (adjusted P‐value: .03) and RINT1 (adjusted P‐value: .04) were significantly associated with hereditary breast and ovarian cancer. However, further studies are required to determinate the risk of cancer, including the segregation of the variants in the families of our cases. No mutation was identified in RAD51, MRE11A, FAM175A, XRCC2, or MLH3. The involvement of these genes in the hereditary predisposition to cancer cannot be ruled out, although if it exists it is rare or does not seem to involve truncating variants.Keywords
This publication has 24 references indexed in Scilit:
- A Review of Whole-Exome Sequencing Efforts Toward Hereditary Breast Cancer Susceptibility Gene DiscoveryHuman Mutation, 2016
- RAD51B in Familial Breast CancerPLOS ONE, 2016
- Cancer predisposition genes: molecular mechanisms and clinical impact on personalized cancer care: examples of Lynch and HBOC syndromesActa Pharmacologica Sinica, 2015
- Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian CancerJNCI: Journal of the National Cancer Institute, 2015
- FANCMc.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factorHuman Molecular Genetics, 2015
- Exome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancerProceedings of the National Academy of Sciences, 2014
- Rare Mutations in RINT1 Predispose Carriers to Breast and Lynch Syndrome–Spectrum CancersCancer Discovery, 2014
- Rare Breast Cancer Subtypes: Histological, Molecular, and Clinical PeculiaritiesThe Oncologist, 2014
- Dominant Mutations in S. cerevisiae PMS1 Identify the Mlh1-Pms1 Endonuclease Active Site and an Exonuclease 1-Independent Mismatch Repair PathwayPLOS Genetics, 2013
- Integrative functional genomics identifies RINT1 as a novel GBM oncogeneNeuro-Oncology, 2012